Evidence map›Paper›PMID 36016925›Full record

ArticleFrontiers in immunology2022

Spatial organization and early signaling of the B-cell receptor in CLL.

Yamit Shorer Arbel, Yotam Bronstein, Tali Dadosh, Talia Kamdjou, Shlomo Tsuriel, Mika Shapiro, Ben-Zion Katz, Yair Herishanu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yamit Shorer ArbelSackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Yotam BronsteinDepartment of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Tali DadoshDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
Talia KamdjouDepartment of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Shlomo TsurielDepartment of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Mika ShapiroDepartment of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ben-Zion KatzSackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Yair HerishanuSackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Tel Aviv Sourasky Medical Center · ILTel Aviv University · ILWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most chronic lymphocytic leukemia (CLL) clones express B-cell receptors (BcR) of both IgM/IgD isotypes; however, 5%-10% of CLL cases express isotype-switched immunoglobulin G (IgG). The early signaling and spatial patterning of the various BcRs at steady state and after activation are still fully unresolved. Herein, we show higher expression of the BcR signalosome elements and a more robust constitutive cell-intrinsic proximal BcR signaling in CLL with unmutated IGHV expressing IgM isotype (IgM U-CLL), compared with IGHV-mutated CLL (M-CLL) expressing either IgM or IgG isotypes. IgM in U-CLL is frequently located in the membrane plane in polarized patches, occasionally in caps, and sometimes inside the cells. Among M-CLL, IgM is scattered laterally in the membrane plane in a similar pattern as seen in normal B cells, whereas IgG is dispersed around the cell membrane in smaller clusters than in IgM U-CLL. Upon BcR engagement, both IgG and IgM expressing M-CLL showed attenuated signaling and only slight spatial reorganization dynamics of BcR microclusters and internalization, compared with the extensive reorganization and internalization of the BcR in IgM expressing U-CLL. The global gene signature of IgG M-CLL was closely related to that of IgM M-CLL rather than IgM U-CLL. Overall, we report fundamental differences in the basal composition, biochemical status, and spatial organization of the BcR in the three examined immunogenetic CLL subtypes that correlate with their clinical behavior. On the basis of our findings, IgG class-switched M-CLL likely represents the same disease as IgM M-CLL rather than a different biological and/or clinical entity.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellHumansImmunoglobulin GImmunoglobulin MReceptors, Antigen, B-CellSignal TransductionImmunoglobulin GImmunoglobulin MReceptors, Antigen, B-CellBCR signalingCLL (chronic lymphocytic leukemia)d-STORMIgGIGHV mutational statusIgM

Identifiers

PMID36016925
PMCPMC9398492
OpenAlexW4292428206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.